Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd Ordinary Shares BMGL Peers
See (BMGL) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BMGL | $1.99 | -6.57% | 37.38M | 22.11 | $0.09 | N/A |
| UNH | $321.59 | +1.80% | 291.73B | 13.47 | $23.88 | +2.62% |
| ANTM | $482.58 | +2.71% | 114.59B | 18.99 | $25.41 | +1.61% |
| ELV | $412.49 | +2.15% | 93.20B | 16.06 | $25.69 | +1.61% |
| CI | $325.00 | +0.94% | 86.82B | 18.12 | $17.94 | +1.76% |
| CVS | $63.74 | +1.53% | 80.63B | 15.21 | $4.19 | +4.18% |
| CNC | $61.96 | +0.67% | 30.83B | 9.14 | $6.78 | N/A |
| HUM | $255.31 | +3.22% | 30.81B | 18.03 | $14.16 | +1.39% |
| MOH | $326.15 | +0.25% | 17.68B | 15.76 | $20.69 | N/A |
| OSCR | $16.47 | -1.67% | 3.61B | 41.18 | $0.40 | N/A |
Stock Comparison
BMGL vs UNH Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 37.38M. In comparison, UNH has a market cap of 291.73B. Regarding current trading prices, BMGL is priced at $1.99, while UNH trades at $321.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 22.11, whereas UNH's P/E ratio is 13.47. In terms of profitability, BMGL's ROE is +0.32%, compared to UNH's ROE of +0.32%. Regarding short-term risk, BMGL is more volatile compared to UNH. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs ANTM Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 37.38M. In comparison, ANTM has a market cap of 114.59B. Regarding current trading prices, BMGL is priced at $1.99, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 22.11, whereas ANTM's P/E ratio is 18.99. In terms of profitability, BMGL's ROE is +0.32%, compared to ANTM's ROE of +0.14%. Regarding short-term risk, BMGL is more volatile compared to ANTM. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs ELV Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 37.38M. In comparison, ELV has a market cap of 93.20B. Regarding current trading prices, BMGL is priced at $1.99, while ELV trades at $412.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 22.11, whereas ELV's P/E ratio is 16.06. In terms of profitability, BMGL's ROE is +0.32%, compared to ELV's ROE of +0.14%. Regarding short-term risk, BMGL is more volatile compared to ELV. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs CI Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 37.38M. In comparison, CI has a market cap of 86.82B. Regarding current trading prices, BMGL is priced at $1.99, while CI trades at $325.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 22.11, whereas CI's P/E ratio is 18.12. In terms of profitability, BMGL's ROE is +0.32%, compared to CI's ROE of +0.12%. Regarding short-term risk, BMGL is more volatile compared to CI. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs CVS Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 37.38M. In comparison, CVS has a market cap of 80.63B. Regarding current trading prices, BMGL is priced at $1.99, while CVS trades at $63.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 22.11, whereas CVS's P/E ratio is 15.21. In terms of profitability, BMGL's ROE is +0.32%, compared to CVS's ROE of +0.07%. Regarding short-term risk, BMGL is more volatile compared to CVS. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs CNC Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 37.38M. In comparison, CNC has a market cap of 30.83B. Regarding current trading prices, BMGL is priced at $1.99, while CNC trades at $61.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 22.11, whereas CNC's P/E ratio is 9.14. In terms of profitability, BMGL's ROE is +0.32%, compared to CNC's ROE of +0.13%. Regarding short-term risk, BMGL is more volatile compared to CNC. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs HUM Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 37.38M. In comparison, HUM has a market cap of 30.81B. Regarding current trading prices, BMGL is priced at $1.99, while HUM trades at $255.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 22.11, whereas HUM's P/E ratio is 18.03. In terms of profitability, BMGL's ROE is +0.32%, compared to HUM's ROE of +0.10%. Regarding short-term risk, BMGL is more volatile compared to HUM. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs MOH Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 37.38M. In comparison, MOH has a market cap of 17.68B. Regarding current trading prices, BMGL is priced at $1.99, while MOH trades at $326.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 22.11, whereas MOH's P/E ratio is 15.76. In terms of profitability, BMGL's ROE is +0.32%, compared to MOH's ROE of +0.26%. Regarding short-term risk, BMGL is more volatile compared to MOH. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs OSCR Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 37.38M. In comparison, OSCR has a market cap of 3.61B. Regarding current trading prices, BMGL is priced at $1.99, while OSCR trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 22.11, whereas OSCR's P/E ratio is 41.18. In terms of profitability, BMGL's ROE is +0.32%, compared to OSCR's ROE of +0.11%. Regarding short-term risk, BMGL is more volatile compared to OSCR. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs ALHC Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 37.38M. In comparison, ALHC has a market cap of 3.10B. Regarding current trading prices, BMGL is priced at $1.99, while ALHC trades at $15.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 22.11, whereas ALHC's P/E ratio is -33.36. In terms of profitability, BMGL's ROE is +0.32%, compared to ALHC's ROE of -0.81%. Regarding short-term risk, BMGL is more volatile compared to ALHC. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs CLOV Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 37.38M. In comparison, CLOV has a market cap of 1.88B. Regarding current trading prices, BMGL is priced at $1.99, while CLOV trades at $3.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 22.11, whereas CLOV's P/E ratio is -92.25. In terms of profitability, BMGL's ROE is +0.32%, compared to CLOV's ROE of -0.07%. Regarding short-term risk, BMGL is more volatile compared to CLOV. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs BHG Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 37.38M. In comparison, BHG has a market cap of 130.51M. Regarding current trading prices, BMGL is priced at $1.99, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 22.11, whereas BHG's P/E ratio is -0.12. In terms of profitability, BMGL's ROE is +0.32%, compared to BHG's ROE of -0.47%. Regarding short-term risk, BMGL is more volatile compared to BHG. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs MRAI Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 37.38M. In comparison, MRAI has a market cap of 17.28M. Regarding current trading prices, BMGL is priced at $1.99, while MRAI trades at $1.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 22.11, whereas MRAI's P/E ratio is -0.40. In terms of profitability, BMGL's ROE is +0.32%, compared to MRAI's ROE of +0.75%. Regarding short-term risk, BMGL is more volatile compared to MRAI. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs IVF Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 37.38M. In comparison, IVF has a market cap of 2.32M. Regarding current trading prices, BMGL is priced at $1.99, while IVF trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 22.11, whereas IVF's P/E ratio is -0.07. In terms of profitability, BMGL's ROE is +0.32%, compared to IVF's ROE of -2.58%. Regarding short-term risk, BMGL is more volatile compared to IVF. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs NIVF Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 37.38M. In comparison, NIVF has a market cap of 2.12M. Regarding current trading prices, BMGL is priced at $1.99, while NIVF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 22.11, whereas NIVF's P/E ratio is -0.01. In terms of profitability, BMGL's ROE is +0.32%, compared to NIVF's ROE of +0.03%. Regarding short-term risk, BMGL is more volatile compared to NIVF. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.